Brevan Howard Capital Management LP Purchases 44,280 Shares of Sotera Health (NASDAQ:SHC)

Brevan Howard Capital Management LP grew its position in Sotera Health (NASDAQ:SHC - Free Report) by 127.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,156 shares of the company's stock after purchasing an additional 44,280 shares during the quarter. Brevan Howard Capital Management LP's holdings in Sotera Health were worth $1,083,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of SHC. Bridgefront Capital LLC purchased a new stake in shares of Sotera Health during the fourth quarter worth about $185,000. BNP Paribas Financial Markets bought a new position in Sotera Health in the 4th quarter worth approximately $208,000. Ananym Capital Management LP purchased a new stake in Sotera Health during the 4th quarter valued at approximately $13,680,000. AXA S.A. raised its position in shares of Sotera Health by 17.1% during the fourth quarter. AXA S.A. now owns 215,629 shares of the company's stock valued at $2,950,000 after buying an additional 31,532 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of Sotera Health by 23.6% in the fourth quarter. Northern Trust Corp now owns 1,334,367 shares of the company's stock worth $18,254,000 after buying an additional 254,768 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $14.00 to $17.00 in a research note on Monday. Piper Sandler cut their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Finally, Barclays dropped their price target on Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $15.80.

Sotera Health Stock Performance

Sotera Health stock opened at $13.16 on Thursday. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $9.53 and a twelve month high of $17.08. The company's 50-day moving average price is $11.39 and its 200-day moving average price is $12.98. The company has a market cap of $3.73 billion, a PE ratio of 52.62 and a beta of 1.88.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The company had revenue of $254.52 million for the quarter, compared to analysts' expectations of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.13 earnings per share. On average, equities research analysts forecast that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.